BNP Paribas Call 700 CTAS 21.06.2.../ DE000PC7Y278 /
12/06/2024 09:50:34 | Var.+0.020 | Denaro10:13:22 | Lettera10:13:22 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.310EUR | +6.90% | 0.320 Quantità in denaro: 9,375 |
0.400 Quantità in lettera: 7,500 |
Cintas Corporation | 700.00 USD | 21/06/2024 | Call |
GlobeNewswire
10:00
Intech Unveils UCITS Fund with Adaptive Volatility and ESG Focus, Anchored by Norway’s Pension Schem...
GlobeNewswire
10:00
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Inves...
GlobeNewswire
10:00
UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated...
GlobeNewswire
10:00
CMBM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cambium Networks Corporation I...
GlobeNewswire
10:00
EXAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Exscientia p.l.c. Investors wi...
GlobeNewswire
10:00
GL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Globe Life Inc. Investors with S...
GlobeNewswire
10:00
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with ...
GlobeNewswire
10:00
MBUU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Malibu Boats, Inc. Investors w...
GlobeNewswire
10:00
BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patient...
GlobeNewswire
09:01
AMERICAN SALARS COMPLETES PHASE 1 EXPLORATION OF BLACK ROCK SOUTH LITHIUM BRINE PROJECT, NV
GlobeNewswire
09:00
Nokia Report reveals enterprises are scaling private wireless for additional uses cases and industri...
GlobeNewswire
08:55
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...